CannaMD

MARCH 4, 2020

Releaf is a free mobile app to help patients track, learn from, and improve their use of medical cannabis. The data that is collected in Releaf App is used for multiple research studies and helps physicians identify what products patients are finding most effective. Patients can learn more by visiting ReleafApp.com.

Patients 79

Patients Data Collective Treatment 79

United Patients Group

JANUARY 4, 2024

As we move forward into 2024 and beyond, the sector offers diverse paths beyond direct patient care. The growth stems from rising healthcare demand, facility expansion, and the imperative for efficient administration to maintain quality patient care. Adverse drug events (ADEs) affect approximately 7 per 100 hospitalized patients.

Research and Development 52

Research and Development Patients Data Policy 52

Cannabis Law Report

JULY 27, 2021

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz and colleagues have published a paper summarizing ORR data from individuals with epilepsy in the medical journal Epilepsy & Behavior. About Realm of Caring.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

NORML

JANUARY 28, 2020

Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. The new data shows 19,990 adults arrested for the same offense in 2019. cannabis arrest data since 2008. cannabis arrest data since 2008.

Marijuana 294

Marijuana Data Decriminalization Policy 294

Veriheal

NOVEMBER 21, 2023

Veriheal recognizes the financial challenges students face in pursuing higher education. Veriheal recognizes that higher education is as expensive as it’s ever been — as such — we’ve increased the scholarship amount to $10,000 each for three deserving winners.

Research and Development 106

Research and Development Consumption Education Data 106

SpeedWeed

AUGUST 31, 2021

16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec. Psychiatric disorders accounted for 11,914 patients.

Programs 72

Programs Patients Dispensary Cultivation 72

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 Funded by Realm of Caring —a non-profit organization committed to redefining cannabis through research and education—this study on CBD and epilepsy was carried out as part of a joint effort with Johns Hopkins University School of Medicine researchers. What is Artisanal CBD?

Epilepsy 66

Epilepsy Pharmaceutical Patients Sleep 66

MMJ Recs

JUNE 15, 2022

The best pain management physicians collaborate with the patient to develop a treatment regimen that works best for them as an individual. They offer top-rated doctors and pain relief specialists that work with each patient to develop a treatment plan tailored to their specific needs. Unique Pain Medicine.

Patients 52

Patients Treatment Clinical Trials Therapy 52

Cannabis Law Report

JULY 7, 2021

Tilray is embarking on a push to educate more German doctors about the benefits of prescribing medical cannabis, as the weed giant seeks to cement its dominance in the highly-profitable European medical market. We also believe that there’s a large amount of observational data.”. Says Market Watch. Source: [link].

Clinical Trials 105

Clinical Trials Education Data Pharmaceutical 105

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

MedicalJane

JUNE 12, 2020

Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. The control group consisted of 271 adult patients who were considering cannabis use, and 197 adult caregivers who were considering it for a dependent child or adult patient.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Veriheal

AUGUST 31, 2020

At Veriheal, education and diversity are at the center of our core values. Choosing only 10 winners for the $10,000 in scholarships among the strong applications we received from multiple disciplines and concentrations in higher education—from students of all backgrounds and interests—was extremely difficult. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

SEPTEMBER 7, 2022

Since the legalisation of medical cannabis in the UK in 2018, there is little education surrounding medical cannabis and how it can help a large variety of conditions, should traditional medicine leave patients with an ‘unmet clinical need.’ .

Patients 52

Patients Conditions Treatment Education 52

Veriheal

JANUARY 7, 2022

Based on the study’s data, the use of cannabis among 12th graders over the last several years has consistently remained around the 35% mark. Whether that exposure happens at a young age or during adulthood, it is essential that folks are educated on it. The Need for Education on Vaping.

Vaping 98

Vaping Education Data Consumption 98

United Patients Group

AUGUST 16, 2023

Accessibility involves digital areas and data in addition to physical infrastructure. By providing assistive technology and fair accommodations for staff and students with disabilities or serious health conditions , employers and educational institutions may also embrace accessibility.

Advocacy 52

Advocacy Education Access Environment 52

Veriheal

JANUARY 23, 2024

This convergence suggests a change in consumer behavior, mostly informed by the growing cannabis education and the evolving state’s regulations. Data revealed a concerning trend. The new regulations include stating the grow location of medical cannabis users, with a provision to upload patients’ photos.

Patients 62

Patients Cannabis Topical Education 62

Cannabis Law Report

SEPTEMBER 29, 2021

With more states legalizing cannabis for medical and recreational use, TCI recognizes the critical role that education plays in reducing patient adverse outcomes and ensuring the safe use of cannabis. TCI was founded by Drs.

Cannabinoids 52

Cannabinoids Education Patients Safety 52

Cannabis Law Report

SEPTEMBER 11, 2021

The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Cannabis Law Report

MAY 12, 2022

Aurora Cannabis announced today that they will be launching a new product line for patients in the United Kingdom. Still, only a small number of patients actually get medical cannabis prescriptions and accessibility is still a hot button issue in the country.

Terpenes 52

Terpenes Extraction Advocacy Patients 52

MMJ Recs

MARCH 16, 2024

Key factors influencing market size and revenue include patient demographics, regulatory frameworks, product offerings, and pricing strategies. Moreover, ensuring product quality and safety throughout the supply chain is paramount to maintain patient trust and regulatory compliance.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

AUGUST 24, 2022

The data suggests we have seen a transition from illicit to legal use of medical cannabis, ” said lead researcher Professor Nicholas Lintzeris , from the Faculty of Medicine and Health at the University of Sydney. More work is required to enhance health provider education regarding medicinal cannabis.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

JULY 13, 2021

The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.

Extraction 105

Extraction Vaping Medicine Patients 105

The Cannigma

AUGUST 31, 2021

Medical societies are slowly providing more CME (continuing medical education) to doctors on cannabis, however, that educational content tends to be slanted toward risk mitigation. Physicians will likely be caring for patients who are using cannabis regardless of their own beliefs about it. We have a ways to go,” Tan said.

Education 101

Education Clinical Trials Medicine Policy 101

Cannabis Law Report

MARCH 27, 2019

New Frontier Data say that they recently presented preliminary findings to the Zimbabwean government while working in collaboration with other regulators in the region to finalize what will be the first “rigorous assessments of both risks and opportunities of hemp cultivation in Africa.” Taxation , CohnReznick (U.S.).

Policy 65

Policy Law Hemp Data 65

Cannabis Law Report

SEPTEMBER 1, 2021

Of note, the number of Independent Testing Laboratories in the Commonwealth increased from three to five in 2021, which the Commission hopes will increase the product supply that is tested, approved, and available to consumers and patients. This past May, the Commission launched the license application for Marijuana Delivery Operators.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

DECEMBER 27, 2019

A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. Cognizance VCT enables the generation of cost-effective quality data with ethical consent, on par with academic studies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

AUGUST 27, 2021

This impressive group represents well-known leaders in the psychedelic and addiction fields and will help usher in a greater understanding of the science and data behind what we expect to be the most effective treatments for many mental health conditions ever available.”. Delic is focused on bringing psychedelic wellness to the mainstream.

Research and Development 98

Research and Development Treatment Media Medicine 98

Veriheal

AUGUST 15, 2022

Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. In the near future, I anticipate that patients will have the opportunity to access more individualized cannabis products, with distinct and known combinations of chemical profiles for treating their specific health needs and lifestyles.”

Treatment 96

Treatment Research and Development Sativa Cannabinoids 96

Cannabis Law Report

OCTOBER 18, 2021

This is an exciting opportunity for Canntab, as we believe 36Eight’s unique and valuable complementary platform will support our ability to provide effective solutions for patients while reinforcing the confidence of patients in their relationship with their clinical pharmacist,” said Larry Latowsky , CEO of Canntab.

Data 52

Data Research and Development Patients Cannabinoids 52

Cannabis Law Report

JUNE 15, 2021

The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Cannabis Law Report

JUNE 6, 2022

has made regulatory and market functionality elusive for most cannabis businesses and the patients and consumers they serve. What is the best way for local governments to receive education and training on effective cannabis policy?

Policy 52

Policy Hemp Education Compliance 52

CannaTech

SEPTEMBER 16, 2018

Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Shedding Stigma and Promoting Patient Access.

Education 66

Education Medicine Clinical Trials Patients 66

The Cannigma

OCTOBER 21, 2021

Still, many patients report that cannabis helps them to feel more in control of their symptoms, leading to important questions. Usually diagnosed in children, ADHD affects around 5% of children and 3% of adults worldwide and can cause challenges for sufferers’ education, work, and home life. Can cannabis help with ADHD?

Blood Pressure 137

Blood Pressure Treatment Patients Cannabis 137

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. I never thought that would have been possible,” he said. However, the results were ultimately inconsistent. Gregory Rec/Staff Photographer.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Illinois News Joint

MAY 27, 2023

So we created Know Your Brand, an educational series to help readers, followers, and consumers learn more about new and established cannabis brands in Illinois. To qualify and receive a medical patient card at a discounted rate, visit here. We kick off our Know Your Brand series with Kaviar. For Illinois News Joint reviews, visit here.

Terpenes 93

Terpenes Strains Dispensary Events 93